Michael J. Schmitt

Array ( [id] => 20466839 [patent_doc_number] => 12522872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy [patent_app_type] => utility [patent_app_number] => 17/357642 [patent_app_country] => US [patent_app_date] => 2021-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 68 [patent_no_of_words] => 19349 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 254 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18451372 [patent_doc_number] => 20230192650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => NOVEL ACID SECRETION INHIBITOR AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/011084 [patent_app_country] => US [patent_app_date] => 2021-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16049 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17561604 [patent_doc_number] => 20220125753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC STROKE [patent_app_type] => utility [patent_app_number] => 17/338172 [patent_app_country] => US [patent_app_date] => 2021-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6748 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17338172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17533953 [patent_doc_number] => 20220112562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => PROGNOSTIC TUMOR BIOMARKERS [patent_app_type] => utility [patent_app_number] => 17/337046 [patent_app_country] => US [patent_app_date] => 2021-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31542 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17256680 [patent_doc_number] => 20210369665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => METHODS OF TREATING VIRAL INFECTION USING PROTEASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/330031 [patent_app_country] => US [patent_app_date] => 2021-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10386 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17330031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18752373 [patent_doc_number] => 20230355605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => DRUG FOR ENHANCING FIBRINOLYTIC SYSTEM, AND USE THEREFOR [patent_app_type] => utility [patent_app_number] => 17/925750 [patent_app_country] => US [patent_app_date] => 2021-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16811 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18413084 [patent_doc_number] => 11667616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Oral GSNOR inhibitor and pharmaceutical use thereof [patent_app_type] => utility [patent_app_number] => 17/628904 [patent_app_country] => US [patent_app_date] => 2021-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 3152 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17434745 [patent_doc_number] => 11260051 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-03-01 [patent_title] => GSNO reductase inhibitor as an adjunct therapy in cerebral thrombosis and/or thromboembolic stroke [patent_app_type] => utility [patent_app_number] => 17/232544 [patent_app_country] => US [patent_app_date] => 2021-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11355 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17232544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17241922 [patent_doc_number] => 20210361665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => TREATMENT OF SKIN LESIONS [patent_app_type] => utility [patent_app_number] => 17/214309 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32526 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17124343 [patent_doc_number] => 20210299111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => EIF4A INHIBITOR COMBINATIONS [patent_app_type] => utility [patent_app_number] => 17/210062 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15452 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18683861 [patent_doc_number] => 11779571 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-10 [patent_title] => Methods for treating irritable bowel syndrome (IBS) [patent_app_type] => utility [patent_app_number] => 17/197561 [patent_app_country] => US [patent_app_date] => 2021-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20004 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17197561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16930776 [patent_doc_number] => 20210196665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => CCL5 Inhibitors [patent_app_type] => utility [patent_app_number] => 17/191196 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12937 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16913875 [patent_doc_number] => 20210186967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => PHARMACEUTICAL FORMULATION [patent_app_type] => utility [patent_app_number] => 17/189091 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12910 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16913804 [patent_doc_number] => 20210186896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION [patent_app_type] => utility [patent_app_number] => 17/187641 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43428 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16883704 [patent_doc_number] => 20210169899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => COMPOSITIONS AND THEIR USE IN ORAL DOSING REGIMENS [patent_app_type] => utility [patent_app_number] => 17/180291 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16754 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17648444 [patent_doc_number] => 11351143 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-06-07 [patent_title] => Methods of treating amyotrophic lateral sclerosis [patent_app_type] => utility [patent_app_number] => 17/169271 [patent_app_country] => US [patent_app_date] => 2021-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11754 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18994544 [patent_doc_number] => 11911360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders [patent_app_type] => utility [patent_app_number] => 17/160009 [patent_app_country] => US [patent_app_date] => 2021-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19430 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17036622 [patent_doc_number] => 20210253580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => ISOQUINOLINE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/156387 [patent_app_country] => US [patent_app_date] => 2021-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59543 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17156387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16976075 [patent_doc_number] => 20210220312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => Compositions And Methods For Modulating Cancer [patent_app_type] => utility [patent_app_number] => 17/150000 [patent_app_country] => US [patent_app_date] => 2021-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17109992 [patent_doc_number] => 20210290589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => METHODS OF PROVIDING SOLRIAMFETOL THERAPY TO SUBJECTS WITH IMPAIRED RENAL FUNCTION [patent_app_type] => utility [patent_app_number] => 17/149406 [patent_app_country] => US [patent_app_date] => 2021-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21072 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17149406 [rel_patent_id] =>[rel_patent_doc_number] =>)